FORT LAUDERDALE, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB US: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) today announced the Company’s consolidated financial results for the fiscal quarter that ended March 31, 2025 (“fiscal quarter 3”). Zefiro also today announced that it has received a Notice of Failure to Pay in connection with a $2 million promissory note ("Note"), created in conjunction with the May 12, 2023, acquisition of Plants and Goodw ...

NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW CALGARY, Alberta, May 14, 2025 (GLOBE NEWSWIRE) -- Alaris Equity Partners Income Trust (“Alaris” or the “Trust”) (TSX: AD.UN) is pleased to announce that as a result of excess demand, it has agreed with the syndicate of underwriters led by National Bank Financial Inc., CIBC Capital Markets, and Desjardins Capital Markets to increase the size of its previously announce ...

FORT WORTH, Texas, May 14, 2025 (GLOBE NEWSWIRE) -- American Airlines Group Inc. (NASDAQ: AAL) Chief Financial Officer, Devon May will present at the 2025 Wolfe Research Global Transportation & Industrials Conference on Thursday, May 22, at 11:15 a.m. CT. A live webcast of the conference will be available at aa.com/investorrelations. About American Airlines GroupAs a leading global airline, American Airlines offers thousands of flights per day to more than 350 destinations in more than 60 countries. The air ...

SANTA MONICA, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Super League Enterprise, Inc. (NASDAQ: SLE) (the “Company”), a leader in redefining how brands connect with consumers through the power of playable media, today announced that the underwriter of its previously announced public offering of common stock has exercised its option to purchase an additional 617,647 shares of common stock at the public offering price of $0.17 per share, resulting in additional gross proceeds of approximately $105,000. After gi ...

America’s Diner unveils delicious new Summer-inspired menu line-up – while doubling down on value! Denny's Limited Time Summer Menu Denny's launches the Red, White and Berry Pancake Slam for a limited time this summer. Denny's Limited Time Summer Menu Denny's launches the Bacon Ranch Cheeseburger and Strawberry Sparkler beverage for a limited time this summer. Spartanburg, SC, May 14, 2025 (GLOBE NEWSWIRE) -- Summer is right around the corner, and Denny’s is ready with new fresh dishes bursting with ...

RYE, N.Y., May 14, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of The Gabelli Equity Trust Inc. (NYSE:GAB) (the “Fund”) reaffirmed and satisfied its 10% distribution policy by declaring a $0.15 per share cash distribution payable on June 23, 2025 to common stock shareholders of record on June 13, 2025. The Fund intends to pay a minimum annual distribution of 10% of the average net asset value of the Fund within a calendar year or an amount sufficient to satisfy the minimum distribution requirements of t ...

Core Insights - Genmab is presenting 14 abstracts on epcoritamab at the 30th European Hematology Association Congress, showcasing its development across various patient populations and treatment settings [1][4] - Epcoritamab is a T-cell engaging bispecific antibody designed for treating diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) [6][7] Development Program - The abstracts include data from Phase 1/2 trials evaluating epcoritamab in combination with other therapies for relapsed/refractory DLBCL and previously untreated DLBCL [2][4] - Key trials include EPCORE NHL-2 and NHL-5, focusing on combinations with rituximab and polatuzumab vedotin [2][5] Presentation Details - Oral presentations will occur on June 15, 2025, featuring significant findings from the EPCORE NHL-2 and NHL-5 trials [5] - Additional results from NHL-1 and NHL-3 trials will be presented as posters, highlighting three years of follow-up data [2][5] Regulatory Status - Epcoritamab has received regulatory approval in specific lymphoma indications in the U.S., Japan, and the EU, and is co-developed with AbbVie [7][10] - The companies are pursuing further international regulatory approvals for additional indications [7] Future Directions - Genmab and AbbVie are conducting five ongoing Phase 3 trials to evaluate epcoritamab's efficacy as a monotherapy and in combination therapies across various hematologic malignancies [8][9] - The companies aim to establish epcoritamab as a core therapy for B-cell malignancies [4][8]

Core Viewpoint - MicroAlgo Inc. has announced the development of the Quantum Information Recursive Optimization (QIRO) algorithm, which aims to enhance combinatorial optimization problems by utilizing quantum computing capabilities [1][7]. Group 1: Algorithm Overview - The QIRO algorithm is designed to tackle complex combinatorial optimization problems by integrating quantum computing and recursive algorithms, leveraging parallel computing and quantum state properties [1][7]. - The algorithm recursively invokes quantum optimization processes, progressively reducing problem size to find optimal solutions [4][7]. Group 2: Technical Process - The first step involves modeling the combinatorial optimization problem by defining the objective function, constraints, and candidate elements [2]. - Quantum states are initialized through quantum gate operations, allowing for simultaneous processing of multiple computational paths [3]. - Quantum measurement is performed at the recursion's boundary conditions to extract optimal or near-optimal solutions [5]. - The extracted solution is verified and optimized by comparing objective function values to identify the best solution [6]. Group 3: Advantages and Applications - The QIRO algorithm demonstrates significant technical advantages, achieving exponential improvements in computational efficiency and stronger global search capabilities compared to traditional algorithms [7]. - It is flexible and can be tailored to meet specific problem requirements, enhancing its effectiveness across various applications [7]. - The algorithm has practical applications in logistics, resource allocation, network planning, and graph theory-related problems, proving its value in real-world scenarios [8]. Group 4: Future Potential - The QIRO algorithm holds immense growth potential as quantum technology advances, improving the quality and accessibility of quantum resources [9][10]. - It may serve as a model for developing additional hybrid quantum-classical algorithms, expanding quantum computing applications across various industries [10]. Group 5: Company Background - MicroAlgo Inc. is dedicated to developing and applying bespoke central processing algorithms, providing comprehensive solutions that enhance customer satisfaction and achieve technical goals [11].

Core Insights - ACV has launched a free digital roundtable series aimed at helping dealers source inventory more effectively and sell vehicles quickly, responding to the increasing demand for expert guidance and actionable data from dealers [1][2] Group 1: Digital Roundtable Series - The series is designed to assist dealers in acquiring more vehicles, including consumer-sourced inventory, and to accelerate vehicle turn times to enhance profitability [1] - The next session, scheduled for May 15, will focus on strategies for effectively acquiring cars from consumers, led by ACV's experts [3] - The roundtable will provide actionable steps and proven tactics for dealers to improve their sourcing strategies, whether they are starting from scratch or optimizing existing processes [5] Group 2: Expert Insights and Solutions - ACV's leadership emphasizes the importance of data-backed solutions powered by AI to help dealers navigate inventory constraints [2] - The sessions will cover high-level strategies and operational solutions, including financing options through ACV Capital, to help dealers scale their consumer vehicle buying [4] - The first session of the series highlighted the use of high fidelity, structured data and AI to enhance dealership performance and profitability [7][9] Group 3: Future Developments - The roundtable series aims to provide insights into pricing intelligence breakthroughs, merchandising solutions, and appraisal standardization [9] - Future sessions will explore on-demand recommendations and the use of AI for inventory decision-making, including pricing and disposition strategies [9] Group 4: Company Mission - ACV is committed to transforming the automotive industry by creating trusted and efficient digital marketplaces and data solutions for sourcing, selling, and managing used vehicles [10]

Annual General Meeting of Shareholders - Approval of a gross dividend of € 1.90 per share- Approval of the proposed appointments and reappointments of Directors On Wednesday 14 May 2025, Bekaert’s Annual General Meeting of Shareholders took place chaired by Jürgen Tinggren, Chairman of the Board of Directors. The following main subjects were considered. The meeting approved the balance sheet and the income statement per 31 December 2024, as submitted by the Board of Directors, including the distribution of ...